Sharma, Arya M.

Effect of semaglutide 2.4 mg on physical functioning and weight‐ and health‐related quality of life in adults with overweight or obesity: Patient‐reported outcomes from the STEP 1–4 trials

Rubino, D., Bjorner, J. B., Rathor, N., Sharma, A. M., von Huth Smith, L., Wharton, S., Wadden, T., Zeuthen, N., & Kolotkin, R. L. (2024) · Diabetes, Obesity and Metabolism

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 56

The Role of Renin—Angiotensin System Blockade in the Management of Hypertension Associated With the Cardiometabolic Syndrome

Sharma, A. M., & Engeli, S. (2006) · Journal of the CardioMetabolic Syndrome

Renin-Angiotensin System StudiesBlood Pressure and Hypertension Studies

Cited by 53

The Potential Role of the Edmonton Obesity Staging System in Determining Indications for Bariatric Surgery

Gill, R. S., Karmali, S., & Sharma, A. M. (2011) · Obesity Surgery

Bariatric Surgery and OutcomesObesity, Physical Activity, Diet

Cited by 42

Hemodynamic and metabolic responses to valsartan and atenolol in obese hypertensive patients

Jordan, J., Engeli, S., Boschmann, M., Weidinger, G., Luft, F. C., Sharma, A. M., & Kreuzberg, U. (2005) · Journal of Hypertension

Blood Pressure and Hypertension StudiesRenin-Angiotensin System Studies

Cited by 41